[1] |
Pundir S, Gridneva Z, Pillai A, et al. Human milk glucocorticoid levels are associated with infant adiposity and head circumference over the first year of life[J]. Front Nutr, 2020,7:166. doi: 10.3389/fnut.2020.00166.
|
[2] |
Rademaker M, Agnew K, Andrews M, et al. Psoriasis in those planning a family, pregnant or breast⁃feeding. The Australasian Psoriasis Collaboration[J]. Australas J Dermatol, 2018,59(2):86⁃100. doi: 10.1111/ajd.12641.
|
[3] |
Kushner CJ, Concha J, Werth VP. Treatment of autoimmune bullous disorders in pregnancy[J]. Am J Clin Dermatol, 2018,19(3):391⁃403. doi: 10.1007/s40257⁃018⁃0342⁃0.
|
[4] |
Lee KM, Kim YS, Seo GS, et al. Use of thiopurines in inflammatory bowel disease: a consensus statement by the Korean association for the study of intestinal diseases (KASID)[J]. Intest Res, 2015,13(3):193⁃207. doi: 10.5217/ir.2015.13. 3.193.
|
[5] |
Patsatsi A, Marinovic B, Murrell D. Autoimmune bullous diseases during pregnancy: solving common and uncommon issues[J]. Int J Womens Dermatol, 2019,5(3):166⁃170. doi: 10.1016/j.ijwd. 2019.01.003.
|
[6] |
Tavakolpour S, Mirsafaei HS, Delshad S. Management of pemphigus disease in pregnancy[J]. Am J Reprod Immunol, 2017,77(1). doi: 10.1111/aji.12601.
|
[7] |
Hoffmann F, Kraft A, Heigl F, et al. Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding[J]. Nervenarzt, 2015,86(2):179⁃186. doi: 10.1007/ s00115⁃014⁃4239⁃8.
|
[8] |
Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum[J]. Clin Dermatol, 2016,34(3):344⁃352. doi: 10.1016/j.clindermatol. 2016.02.006.
|
[9] |
Chi CC, Wang SH, Kirtschig G. Safety of topical corticosteroids in pregnancy[J]. JAMA Dermatol, 2016,152(8):934⁃935. doi: 10.1001/jamadermatol.2016.1009.
|
[10] |
Chi CC, Kirtschig G, Aberer W, et al. Updated evidence⁃based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy[J]. J Eur Acad Dermatol Venereol, 2017,31(5):761⁃773. doi: 10.1111/jdv.14101.
|
[11] |
Zhao CY, Chiang YZ, Murrell DF. Neonatal autoimmune blistering disease: a systematic review[J]. Pediatr Dermatol, 2016,33(4):367⁃374. doi: 10.1111/pde.12859.
|
[12] |
Pawar M, Singh M. Systemic steroids and risk of fecal⁃oral shedding and increased transmission of SARS⁃CoV⁃2 in pemphigus cases[J]. Clin Dermatol, 2020,38(6):750⁃756. doi: 10.1016/j.clindermatol.2020.06.006.
|
[13] |
Campanati A, Brisigotti V, Diotallevi F, et al. Active implications for dermatologists in ′SARS⁃CoV⁃2 ERA′: personal experience and review of literature[J]. J Eur Acad Dermatol Venereol, 2020,34(8):1626⁃1632. doi: 10.1111/jdv.16646.
|
[14] |
Elmas ÖF, Demirbaş A, Türsen Ü, et al. Pemphigus and COVID⁃19: Critical overview of management with a focus on treatment choice[J]. Dermatol Ther, 2020,33(6):e14265. doi: 10.1111/dth.14265.
|
[15] |
Kasperkiewicz M, Yale M, Strong R, et al. COVID⁃19 pandemic and autoimmune bullous diseases: a cross⁃sectional study of the International Pemphigus and Pemphigoid Foundation[J]. J Eur Acad Dermatol Venereol, 2021,35(7):e418⁃e421. doi: 10.1111/jdv.17228.
|
[16] |
Atarzadeh F, Daneshfard B, Dastgheib L, et al. Early description of diet⁃induced blistering skin diseases in medieval Persia: Avicenna′s point of view[J]. Skinmed, 2016,14(5):367⁃370.
|
[17] |
Kneiber D, Kowalski EH, Kridin K, et al. Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation[J]. J Eur Acad Dermatol Venereol, 2019,33(10):1935⁃1940. doi: 10.1111/ jdv.15731.
|
[18] |
Pedroni MN, Hirotsu C, Porro AM, et al. The role of sleep in pemphigus: a review of mechanisms and perspectives[J]. Arch Dermatol Res, 2017,309(8):659⁃664. doi: 10.1007/s00403⁃017⁃1765⁃9.
|
[19] |
Li F, Wu Y, Bian W, et al. Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single⁃center retrospective study[J]. Ann Clin Microbiol Antimicrob, 2020,19(1):46. doi: 10.1186/s12941⁃020⁃00388⁃6.
|
[20] |
Takahashi H, Iriki H, Mukai M, et al. Autoimmunity and immunological tolerance in autoimmune bullous diseases[J]. Int Immunol, 2019,31(7):431⁃437. doi: 10.1093/intimm/dxz030.
|